Literature DB >> 34899962

Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.

Divya Bhansali1, Shavonne L Teng2,3,4, Caleb S Lee1, Brian L Schmidt5, Nigel W Bunnett3,4, Kam W Leong1,6.   

Abstract

Pain is one of the most common medical conditions and affects more Americans than diabetes, heart disease, and cancer combined. Current pain treatments mainly rely on opioid analgesics and remain unsatisfactory. The life-threatening side effects and addictive properties of opioids demand new therapeutic approaches. Nanomedicine may be able to address these challenges as it allows for sensitive and targeted treatments without some of the burdens associated with current clinical pain therapies. This review discusses the physiology of pain, the current landscape of pain treatment, novel targets for pain treatment, and recent and ongoing efforts to effectively treat pain using nanotechnology-based approaches. We highl ight advances in nanoparticle-based drug delivery to reduce side effects, gene therapy to tackle the source of pain, and nanomaterials-based scavenging to proactively mediate pain signaling.

Entities:  

Keywords:  CRISPR; ROS scavenging; drug delivery; gene therapy; nanomedicine; pain

Year:  2021        PMID: 34899962      PMCID: PMC8654201          DOI: 10.1016/j.nantod.2021.101223

Source DB:  PubMed          Journal:  Nano Today        ISSN: 1748-0132            Impact factor:   18.962


  202 in total

1.  Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast.

Authors:  Magdalena Hryhorowicz; Bartosz Grześkowiak; Natalia Mazurkiewicz; Paweł Śledziński; Daniel Lipiński; Ryszard Słomski
Journal:  Mol Biotechnol       Date:  2019-03       Impact factor: 2.695

Review 2.  Opioid Therapy and its Side Effects: A Review.

Authors:  Hooman Khademi; Farin Kamangar; Paul Brennan; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2016-12       Impact factor: 1.354

3.  Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.

Authors:  Douglas W Losordo; Peter R Vale; Robert C Hendel; Charles E Milliken; F David Fortuin; Nancie Cummings; Richard A Schatz; Takayuki Asahara; Jeffrey M Isner; Richard E Kuntz
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

Review 4.  Nanotechnology: A Promising New Paradigm for the Control of Pain.

Authors:  Krishnan V Chakravarthy; Frank J Boehm; Paul J Christo
Journal:  Pain Med       Date:  2018-02-01       Impact factor: 3.750

5.  Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management.

Authors:  Jigar Lalani; Sushilkumar Patil; Atul Kolate; Riddhi Lalani; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2014-10-30       Impact factor: 3.246

6.  Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Authors:  J Braz; C Beaufour; A Coutaux; A L Epstein; F Cesselin; M Hamon; M Pohl
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

7.  Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials.

Authors:  Timothy D Henry; Cindy L Grines; Matthew W Watkins; Nabil Dib; Gerald Barbeau; Randall Moreadith; Tony Andrasfay; Robert L Engler
Journal:  J Am Coll Cardiol       Date:  2007-08-24       Impact factor: 24.094

Review 8.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

9.  Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.

Authors:  Jun-Jie Yin; Fang Lao; Jie Meng; Peter P Fu; Yuliang Zhao; Gengmei Xing; Xueyun Gao; Baoyun Sun; Paul C Wang; Chunying Chen; Xing-Jie Liang
Journal:  Mol Pharmacol       Date:  2008-07-17       Impact factor: 4.436

10.  A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine.

Authors:  Jiao Feng; Sinda Lepetre-Mouelhi; Anne Gautier; Simona Mura; Catherine Cailleau; François Coudore; Michel Hamon; Patrick Couvreur
Journal:  Sci Adv       Date:  2019-02-13       Impact factor: 14.136

View more
  6 in total

1.  Injectable electrospun fiber-hydrogel composite sequentially releasing clonidine and ropivacaine for prolonged and walking regional analgesia.

Authors:  Sufang Chen; Weifeng Yao; Haixia Wang; Tienan Wang; Xue Xiao; Guoliang Sun; Jing Yang; Yu Guan; Zhen Zhang; Zhengyuan Xia; Mingqiang Li; Yu Tao; Ziqing Hei
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

2.  Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Authors:  Giuseppe Forte; Valentina Giuffrida; Angelica Scuderi; Mariella Pazzaglia
Journal:  Biomedicines       Date:  2022-06-10

3.  A Novel Photoswitchable Azobenzene-Containing Local Anesthetic Ethercaine with Light-Controlled Biological Activity In Vivo.

Authors:  Alexey Noev; Nikita Kuznetsov; Georgiy Korenev; Natalia Morozova; Yuriy Vasil'ev; Nikita Suvorov; Ekaterina Diachkova; Maksim Usachev; Andrei Pankratov; Mikhail Grin
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

4.  "Compoundless Anaesthesia", Controlled Administration, and Post-Operative Recovery Acceleration: Musings on Theoretical Nanomedicine Applications.

Authors:  Tyler Lance Jaynes
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

5.  Moderate-Intensity Ultrasound-Triggered On-Demand Analgesia Nanoplatforms for Postoperative Pain Management.

Authors:  Xinye Song; Mengxiao Luan; Weiyi Zhang; Ruizheng Zhang; Li Xue; Yong Luan
Journal:  Int J Nanomedicine       Date:  2022-07-23

Review 6.  Biomaterials and Regenerative Medicine in Pain Management.

Authors:  Xingjian Gu; Michelle A Carroll Turpin; Mario I Romero-Ortega
Journal:  Curr Pain Headache Rep       Date:  2022-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.